Items where Author is "Muller-Brand, J."

2013

Marincek, N. and Jorg, A. C. and Brunner, P. and Schindler, C. and Koller, M. T. and Rochlitz, C. and Muller-Brand, J. and Maecke, H. R. and Briel, M. and Walter, M. A.. (2013) Somatostatin-based radiotherapy with [90Y-DOTA]-TOC in neuroendocrine tumors : long-term outcome of a phase I dose escalation study. Journal of translational medicine, Vol. 11 , 17. p. 17.

2012

Villard, L. and Romer, A. and Marincek, N. and Brunner, P. and Koller, M. T. and Schindler, C. and Ng, Q. K. and Macke, H. R. and Muller-Brand, J. and Rochlitz, C. and Briel, M. and Walter, M. A.. (2012) Cohort study of somatostatin-based radiopeptide therapy with [(90)Y-DOTA]-TOC versus [(90)Y-DOTA]-TOC plus [(177)Lu-DOTA]-TOC in neuroendocrine cancers. Journal of clinical oncology : official journal of the American Society of Clinical Oncology, Vol. 30, H. 10. pp. 1100-1106.

2009

Walter, M. A. and Schindler, C. and Christ-Crain, M. and Muller-Brand, J. and Muller, B.. (2009) Different strategies to overcome the effect of carbimazole on high- and low-dose radioiodine therapy: results from continuous dose-effect models. European Journal of Clinical Investigation, 39 (1). pp. 51-57.

2007

Walter, M. A. and Briel, M. and Christ-Crain, M. and Bonnema, S. J. and Connell, J. and Cooper, D. S. and Bucher, H. C. and Muller-Brand, J. and Muller, B.. (2007) Effects of antithyroid drugs on radioiodine treatment: systematic review and meta-analysis of randomised controlled trials. Bmj, 334 (7592). p. 514.

Iten, F. and Muller, B. and Muller-Brand, J. and Walter, M. A.. (2007) Nuklearmedizin: Die systemische Radionuklidtherapie beim metastasierten medullären Schilddrüsenkarzinom. Schweizerisches Medizin-Forum, 7 (1). pp. 21-22.

Iten, F. and Muller, B. and Schindler, C. and Rochlitz, C. and Oertli, D. and Macke, H. R. and Muller-Brand, J. and Walter, M. A.. (2007) Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial. Clinical Cancer Research, 13 (22). pp. 6696-6702.

Walter, M. A. and Turtschi, C. P. and Schindler, C. and Minnig, P. and Muller-Brand, J. and Muller, B.. (2007) The dental safety profile of high-dose radioiodine therapy for thyroid cancer: long-term results of a longitudinal cohort study. Journal of Nuclear Medicine, 48 (10). pp. 1620-1625.

2006

Walter, M. A. and Seboek, D. and Demougin, P. and Bubendorf, L. and Oberholzer, M. and Muller-Brand, J. and Muller, B.. (2006) Extraction of high-integrity RNA suitable for microarray gene expression analysis from long-term stored human thyroid tissues. Pathology, 38 (3). pp. 249-253.

Walter, M. A. and Christ-Crain, M. and Schindler, C. and Muller-Brand, J. and Muller, B.. (2006) Outcome of radioiodine therapy without, on or 3 days off carbimazole: a prospective interventional three-group comparison. European Journal of Nuclear Medicine and Molecular Imaging, 33 (6). pp. 730-737.

2005

Walter, M. A. and Christ-Crain, M. and Muller, B. and Muller-Brand, J.. (2005) Radioiodine uptake and thyroid hormone levels on or off simultaneous carbimazole medication: a prospective paired comparison. Nuklearmedizin, 44 (1). pp. 33-36.

2004

Walter, M. A. and Christ-Crain, M. and Eckard, B. and Schindler, C. and Nitzsche, E. U. and Muller-Brand, J. and Muller, B.. (2004) Radioiodine therapy in hyperthyroidism: inverse correlation of pretherapeutic iodine uptake level and post-therapeutic outcome. European Journal of Clinical Investigation, 34 (5). pp. 365-370.